Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...
Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...
No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...
GlobalData on MSN11d
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance deviceThe US Food and Drug Administration (FDA) has granted 510(k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for ...
Zacks.com on MSN11d
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance DeviceInogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...
Medicare covers 80% of the costs of oxygen equipment rental after a person has met the yearly deductible. If someone wishes to purchase a portable oxygen concentrator, Medicare will help pay for ...
“Respiratory care is lifesaving for so many patients, but too often access to this care is cost-prohibitive or ... rate cuts for items such as an oxygen concentrator (the bill would essentially ...
Inogen’s co-founders in 2014 at the company’s IPO ... were students at UC Santa Barbara when they won a university competition with their idea for a portable oxygen concentrator. With her departure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback